Brief: Passage Bio Reports Fourth Quarter and Full Year 2024 Results

Passage Bio

04/03/2025 12:07

March 4 (Reuters) - Passage Bio Inc PASG.O:

PASSAGE BIO FY NET INCOME USD -64.767 MILLION

PASSAGE BIO FY INCOME FROM OPERATIONS USD -70.4 MILLION

EXTENDED CASH RUNWAY INTO 1Q 2027

NET LOSS $12.7 MILLION, OR $0.20 PER BASIC AND DILUTED SHARE FOR Q4 2024

Q4 EARNINGS PER SHARE VIEW $-0.20 -- LSEG IBES DATA

Source text: ID:nGNX2J8hqr

Further company coverage: PASG.O

 ((Reuters.Briefs@thomsonreuters.com;))